Programmed cell death 4 (Pdcd4) was originally identified as a gene activated during apoptosis (Shibahara et al., 1995) . Subsequent studies using an in-vitro mouse keratinocyte model of tumor promotion (Cmarik et al., 1999) and an in-vivo mouse model of skin carcinogenesis (Jansen et al., 2005) showed that Pdcd4 functions as a tumor suppressor gene. Further analysis showed that Pdcd4 expression is reduced in human lung-, renal-and glia-derived tumors, and this contributes to their progression (Chen et al., 2003; Jansen et al., 2005; Zhang et al., 2006; Mudduluru et al., 2007; Wang et al., 2008) . Together, these observations have established Pdcd4 as a new tumor suppressor gene.
Pdcd4 encodes a highly conserved 55 kDa nuclear protein that is able to shuttle to the cytoplasm (Bo¨hm et al., 2003) . Pdcd4 is comprised of two so-called MA-3 domains, which occupy the central and the C-terminal part of the protein, and an N-terminal domain which exhibits intrinsic RNA-binding activity. The steady-state level and subcellular localization of Pdcd4 are controlled through multiple mechanisms. Pdcd4 mRNA is targeted by the oncogenic micro-RNA, miR-21, overexpression of which downregulates Pdcd4 expression (Asangani et al., 2008; Frankel et al., 2008; Lu et al., 2008) . On the protein level, S6K-mediated phosphorylation of Pdcd4 triggers its ubiquitinylation by the E3 ubiquitin ligase complex SCF (bTRCP) and its subsequent degradation (Dorello et al., 2006) . The subcellular localization of Pdcd4 is controlled by a protein kinase Akt-mediated phosphorylation (Bo¨hm et al., 2003; Palamarchuk et al., 2005) . So far, multiple functions have been ascribed to Pdcd4. Pdcd4 interacts with the eukaryotic translation initiation factor eIF4A and inhibits the helicase activity of eIF4A (Go¨ke et al., 2002 : Yang et al., 2003a LaRondeBlanc et al., 2007; Waters et al., 2007) . Pdcd4 binds to eIF4A through its MA-3 domains, structure and complex formation with eIF4A of which have been analyzed in great detail (LaRonde-Blanc et al., 2007; Waters et al., 2007; Suzuki et al., 2008; Chang et al., 2009; Loh et al., 2009) . eIF4A catalyzes the unwinding of stable secondary structure in the 5 0 untranslated region of mRNAs, thereby allowing the recruitment of the 40S ribosomal subunit to the 5 0 cap of mRNA (Hershey and Merrick, 2000) . Overall, these findings have suggested that Pdcd4 suppresses the translation of mRNAs with 5 0 structured untranslated regions.
In addition to its role as a translation suppressor, Pdcd4 affects the transcription of genes, apparently by interfering with specific transcription factors, such as AP-1 (Yang et al., 2003b; Bitomsky et al., 2004) , Sp1 and p53 (Bitomsky et al., 2008) .
Here, we have used the DT40 cell line, a chicken B-cell line that shows exceptionally high frequencies of homologous recombination (Buerstedde and Takeda, 1991) , as a model system to study the role of Pdcd4 by gene disruption. Genomic clones of the chicken Pdcd4 gene (Schlichter et al., 2001) were used to generate targeting constructs, in which, parts of the Pdcd4 gene were replaced by histidinol or puromycin resistance cassettes (Figures 1a and b) . DT40 cells transfected with the histidinol-targeting construct were selected in the presence of 0.5 mg/ml histidinol and resulting clones were analyzed by Southern blotting for disruption of one copy of the Pdcd4 gene. A positive clone was identified by the appearance of an approximately 7-kb new ApaI restriction fragment (Figure 1c) . This clone was then transfected with the puromycin-targeting construct and selected in the presence of 1 mg/ml puromycin. Doubly resistant clones were then analyzed by Southern blotting to identify cells in which both copies of Pdcd4 had been disrupted. Targeting of the second copy of the Pdcd4 gene led to the disappearance of the 13-kb parental ApaI fragment and the appearance of a new 8.3-kb ApaI fragment. The Southern blot shown in Figure 1c illustrates the successful targeting of both copies of the Pdcd4 gene.
To confirm the absence of Pdcd4 mRNA and protein in the knockout cells we analyzed wild-type ( þ / þ ), single ( þ /À) and two clones of double (À/À) knockout cells by northern blotting and immunoprecipitation. As shown in Figure 1d , Pdcd4 mRNA was expressed at reduced levels in ( þ /À) cells and was undetectable in the (À/À) cells. Using an antiserum raised against bacterially expressed chicken Pdcd4, the endogenous protein was immunoprecipitated as an approximately 55 000-Mr polypeptide that was no longer detected in the (À/À) cells (Figure 1e ). These data confirm that we have successfully disrupted both copies of Pdcd4 by homologous recombination.
The finding that Pdcd4 knockout cells are viable showed that Pdcd4 is not essential for DT40 cells. DT40 The targeting vectors were generated by first cloning a 2.7-kb SacI/BamHI fragment containing exons 3 and 4 as well as intron sequences for Pdcd4, and a BamHI/XhoI fragment with a histidinol or puromycin resistance cassette containing the chicken b-actin promoter and the puromycin or histidinol resistance gene (Bezzubova et al., 1997) between the SacI and XhoI sites of pbluescript. Subsequently, a fragment from the 3 0 part of the gene was inserted between the XhoI and KpnI sites of the plasmid. In case of the histidinol construct, a 0.6-kb fragment amplified by PCR from the last exon of the gene was used. In case of the puromycin-targeting construct a 2.2-kb fragment containing exons 8-10 and intervening sequences was inserted. Exons of Pdcd4 are indicated by black boxes. Relevant ApaI (A), BamHI (Ba), KpnI (Kp), SacI (S) and XhoI (Xh) restriction sites are shown. (c) Southern blot hybridization of ApaI-digested DNA of wild type (lane 1), heterozygous mutant (lane 4) and two homozygous mutant (lanes 2 and 3) clones using a 1.6-kb fragment from the 5 0 side of the Pdcd4 gene (indicated by a black bar in a and b) as probe. (d) mRNA from wild-type DT40 cells ( þ / þ , lane 1), heterozygous mutant clone ( þ /À, lane 2) and two clones of homozygous mutant cells (À/À, lanes 3 and 4) were analyzed by northern blotting with probes specific for Pdcd4 (top) and ribosomal protein S17 mRNAs (bottom). (e) Whole-cell lysates of 35 S-methionine labelled wild type ( þ / þ , lane 1), heterozygous mutant ( þ /À, lane 2) and two clones of homozygous mutant DT40 cells (À/À, lanes 3 and 4) were immunoprecipitated using antiserum against chicken Pdcd4, followed by SDS-PAGE and autoradiography. The Pdcd4 protein is marked by an arrow.
( þ / þ ), ( þ /À) and (À/À) cells grew with indistinguishable doubling times of approximately 12 h (Figure 2a) , indicating that the loss of Pdcd4 had no effect on the overall proliferation rate of the cells. We also determined the cell-cycle distribution of the ( þ / þ ), ( þ /À) and (À/À) cell populations using flow cytometry and found that the fractions of the cells residing in different cell-cycle phases were similar for each cell population (Figure 2b) . Thus, the loss of Pdcd4 did not result in proliferation defects or distortions of the cell cycle.
As we had previously observed that the knock down of Pdcd4 in a human cell line alters the response of the cells to UV irradiation (Bitomsky et al., 2008) , we were interested to investigate the effect of UV light on the DT40 Pdcd4 ( þ / þ ) and (À/À) cells. We used two different assays to measure cell viability after exposure to UV light. Figure 3a illustrates the results of a softagar colony formation assay using DT40 wild-type cells as well as two different clones of Pdcd4 (À/À) cells. The cells were irradiated with different doses of UV light, plated in semisolid medium and colonies were counted after several days. Pdcd4-deficient cells showed a much stronger decrease of the clonogenic potential than wildtype cells in response to UV irradiation. As a short-term assay of the proliferative capacity, we measured the ability of the cells to synthesize DNA. DT40 wild-type and Pdcd4 (À/À) cells were subjected to different doses of UV irradiation, cultivated for 24 h and then labelled for one hour with 3 H-thymidine (Figure 3b) . Analysis of the amount of radioactivity incorporated into DNA showed that the proliferative activity of the irradiated cells decreased strongly as the UV dose was increased. Consistent with the colony forming assay, Pdcd4 (À/À) cells were much more sensitive to UV irradiation than wild-type cells. To exclude the possibility that the increased UV sensitivity of the Pdcd4 knockout cells was due to clonal variation we re-expressed a hemagglutinin-tagged version of chicken Pdcd4 in the knockout cells. The analysis of the resulting cells by 3 Hthymidine incorporation and colony formation showed that the Pdcd4 re-expressing cells were again more resistant to UV irradiation than the knockout cells (Figures 3c-e) . This confirmed that the loss of Pdcd4 expression was responsible for the increased sensitivity of the knockout cells.
To investigate whether Pdcd4 (À/À) cells were also more sensitive than wild-type cells to other DNAdamaging agents, we compared the viability of Pdcd4 ( þ / þ ) and (À/À) cells after treatment with a topoisomerase inhibitor, etoposide, or an alkylating reagent, ethyl-methanesulfonate. As shown in Figure 4 , Pdcd4-deficient cells were more sensitive to both DNAdamaging agents than wild-type cells. Moreover, re-expression of Pdcd4 in the knockout cells again decreased their sensitivity towards EMS-or etoposideinduced damage, indicating that the observed differences were not due to clonal variation. Taken together, these experiments establish that the Pdcd4 knockout cells show increased sensitivity towards different DNA-damaging agents and provide strong evidence that Pdcd4 is involved in the cellular response to genotoxic stress.
Using siRNA-mediated knock down of Pdcd4 in HeLa cells, we have recently observed that cells with decreased Pdcd4 expression show increased survival after UV irradiation compared with control cells (Bitomsky et al., 2008) . We also found that Pdcd4 knockdown was accompanied by increased expression of the p53-regulated gene p21 (Waf1/Cip1), suggesting that Pdcd4 exerts inhibitory effects on p53. Furthermore, we showed that these inhibitory effects were due to the inhibition of p300-mediated acetylation of p53 by Pdcd4 (Bitomsky et al., 2008) . The upregulation of p21 (Waf1/Cip1) after Pdcd4 knockdown suppressed apoptosis and facilitated the survival of the cells after UV irradiation, consistent with the anti-apoptotic role of p21 (Waf1/Cip1) (Gorospe et al., 1997; Seoane et al., 2002) . Surprisingly, as we have shown here, the loss of Pdcd4 in DT40 cells had the opposite effect on the survival of the cells after UV-induced DNA damage. As Pdcd4's role in DNA-damage response P Singh et al DT40 cells do not express p53 (Takao et al., 1999) , we considered the possibility that the p53 expression status of a cell might have a major impact on its response to DNA damage after Pdcd4 knockdown. To test this idea, we compared the effect of Pdcd4 downregulation in HCT116 p53 wild-type and p53-deficient cells. Figure 5a shows that transfection with Pdcd4-specific siRNA caused a comparable knockdown of Pdcd4 in both cell lines. Control siRNA-or Pdcd4 siRNA-treated cells were then UV irradiated and plated in tissue culture dishes to determine their ability to form colonies. Consistent with our previous study (Bitomsky et al., 2008) , p53-expressing cells formed more colonies after knockdown of Pdcd4 (Figure 5b , left panels). By Pdcd4's role in DNA-damage response P Singh et al contrast, the response of the p53-deficient cells was reversed, that is, knock down of Pdcd4 diminished their ability to survive and to form colonies (Figure 5b , right panels). This is consistent with the behaviour of the DT40 Pdcd4-deficient cells and strongly supports the idea that the p53 status has a major influence on the cellular DNA-damage response after a decrease in Pdcd4 expression. In p53-positive cells, downregulation of Pdcd4 increases p53 activity leading to an increased p21 (Waf1/Cip1) expression and increased survival after UV irradiation, as shown before (Bitomsky et al., 2008) . In the absence of p53, as exemplified here by the DT40 and HCT116 p53-deficient cells, the downregulation of Pdcd4 exerts opposite effects on the survival of cells after UV-induced DNA damage. Our study, therefore, suggests that in addition to modulating p53 activity, Pdcd4 also affects the cellular response to DNA damage in a p53-independent manner.
Previous studies have shed light on the mechanism by which Pdcd4 suppresses tumorigenesis. Several reports have suggested that decreased Pdcd4 expression, which is frequently observed in cancer cells, increases the invasive properties of tumor cells. An overexpression of Pdcd4 in a metastatic colon carcinoma cell line suppressed the invasiveness of the cells in a migration assay (Yang et al., 2006) . Conversely, shRNA-mediated knockdown of Pdcd4 expression in a non-invasive colon carcinoma cell line promoted invasive growth of the cells (Wang et al., 2008) . In addition, overexpression of Pdcd4 inhibits the expression of the urokinase-type plasminogen activator receptor, a cell surface protein that mediates the degradation of extracellular matrix components, and promotes tumor cells invasion and metastasis . Our data highlight a new aspect of Pdcd4 that is likely to be relevant for its role in tumor development. Our study suggests that the downregulation or absence of Pdcd4 disturbs the cellular DNA-damage response, which might affect genomic stability and cause mutations in other genes. The exact mechanism by which Pdcd4 acts at the molecular level to allow cells to cope with genotoxic stress remains to be elucidated. A likely possibility is that Pdcd4 is involved Pdcd4's role in DNA-damage response P Singh et al in the transcription or the translation of genes which themselves are involved in DNA-damage response.
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